Family Office Of America (FOFA) Selling, General & Administrative (2021 - 2026)

Family Office Of America (FOFA) Selling, General & Administrative (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Abbott Laboratories 181.32 Bn 174.03 Bn 6.27 Bn 3.74 Bn
2 Stryker 128.59 Bn 125.71 Bn 3.81 Bn 2.28 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 3.06 Bn
4 Boston Scientific 67.77 Bn 66.32 Bn 3.61 Bn 1.78 Bn
5 Edwards Lifesciences 48.13 Bn 44.46 Bn 1.29 Bn 522.20 Mn
6 GE HealthCare Technologies 28.44 Bn 26.15 Bn 1.98 Bn 1.12 Bn
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn 349.70 Mn
8 Smith & Nephew 26.77 Bn 26.20 Bn - -
9 Koninklijke Philips 25.24 Bn 22.11 Bn 2.07 Bn -207.22 Mn
10 Family Office Of America 27.22 Mn 26.88 Mn 783,126.00 477,648.00

Historic Data

Download Data
DateValue
Mar 31, 2026 477,648.00
Dec 31, 2025 408,800.00
Sep 30, 2025 26,161.00
Jun 30, 2025 50,508.00
Mar 31, 2025 30,746.00
Dec 31, 2024 29,040.00
Sep 30, 2024 21,438.00
Jun 30, 2024 30,102.00
Mar 31, 2024 16,160.00
Dec 31, 2023 28,625.00
Sep 30, 2023 28,572.00
Jun 30, 2023 34,653.00
Mar 31, 2023 78,311.00
Dec 31, 2022 -82,769.00
Sep 30, 2022 126,659.00
Jun 30, 2022 465,111.00
Mar 31, 2022 82,906.00
Dec 31, 2021 117,719.00
Sep 30, 2021 396,932.00
Jun 30, 2021 328,920.00